Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases working group on the pathophysiology of obesity-associated cardiovascular disease

Circulation

Volumn 105, Issue 24, 2002, Pages 2923-2928

  Eckel, Robert H ^a   Barouch, Winifred W ^a   Ershow, Abby G ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Atherosclerosis; Diabetes mellitus; Hypertension; Stroke; Thrombosis

Indexed keywords

ANDROGEN; ANGIOTENSIN; ANGIOTENSINOGEN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; ESTROGEN; FATTY ACID; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ATHEROSCLEROSIS; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; EPIDEMIC; HUMAN; HYPERINSULINEMIA; INFLAMMATION; KIDNEY DISEASE; LIPID METABOLISM; METABOLISM; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH; RACE; REVIEW; SEX DIFFERENCE; STROKE; THROMBOSIS; UNITED STATES;

ADIPOSE TISSUE; ANIMALS; ARTERIOSCLEROSIS; BIOTECHNOLOGY; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FATTY ACIDS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERINSULINISM; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LIPID METABOLISM; MALE; MYOCARDIUM; NATIONAL INSTITUTES OF HEALTH (U.S.); OBESITY; RESEARCH DESIGN; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; THROMBOSIS; UNITED STATES;

EID: 0037129907     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000017823.53114.4C     Document Type: Review

References (48)

1. Obesity evaluation and treatment: Expert committee recommendations
2. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents
3. Coexistence of increased levels of adiposity, insulin, and blood pressure in a young adult cohort with elevated very-low-density lipoprotein cholesterol: The Bogalusa Heart Study
4. Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome
5. Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects
6. Suppression of whole body and regional lipolysis by insulin: Effects of obesity and exercise
7. Cardiovascular morbidity and mortality associated with the metabolic syndrome
8. Abnormal regulation of the leptin gene in the pathogenesis of obesity
9. Obesity hypertension: Role of leptin and sympathetic nervous system
10. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea
11. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action
12. Fat cell metabolism: Insulin, fatty acids, and renin
13. Regulation of fatty acid homeostasis in cells: Novel role of leptin
14. Lipotoxic heart disease in obese rats: Implications for human obesity
15. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats
16. Non-alcoholic steatohepatitis
17. Cardiac conduction system involvement in sudden death of obese young people
18. Inflammatory markers of coronary risk
19. The adipocyte and hemostatic balance in obesity: Studies of PAI-1
20. A prospective study of risk factors for pulmonary embolism in women
21. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity
22. Neural and humoral mechanisms mediating cardiovascular responses to obstructive sleep apnea
23. Pathophysiology of obesity hypertension
24. Sympathetic neural mechanism in obstructive sleep apnea
25. Neural mechanisms in human obesity-related hypertension
26. Obesity and the hypothalamus: Novel peptides for new pathways
27. Circulating lipoprotein profiles are modulated differently by lipoprotein lipase in obese humans
28. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1
29. Insulin resistance and cardiovascular disease
30. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
31. Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: Effects on lipoprotein and atherosclerosis
32. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
33. Calorie restriction in obesity: Prevention of kidney disease in rodents
34. Functional and structural changes in the kidney in the early stages of obesity
35. Obesity-related glomerulopathy: An emerging epidemic
36. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia
37. Insulin resistance differentially affects the PI 3-kinase-and MAP kinase-mediated signaling in human muscle
38. Impact of overweight on the risk of developing common chronic diseases during a 10-year period
39. Risk factors for congestive heart failure in US men and women
40. The disease burden associated with overweight and obesity
41. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study
42. Body fat distribution, obesity, overweight and stroke incidence in women and men: The NHANES I Epidemiologic Follow-up Study
43. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women
44. Hormone replacement therapy and heart disease prevention: Experimentation trumps observation